HPV Specimen Self-Collection for Cervical Cancer Screening Introduced by Quest
Quest Diagnostics has introduced a self-collection option for HPV screening, improving access to cervical cancer prevention.
Quest Diagnostics has introduced a self-collection option for HPV screening, improving access to cervical cancer prevention.
A new study highlights support among healthcare providers for HPV self-collection, which could improve access to cervical cancer screening.
BD partnered with Camtech Health to advance cervical cancer screening by offering women in Singapore the option to self-collect a sample.
Only 19% of Saudi Arabian women are diagnosed with stage I cervical cancer where survival rates are highest, according to a new study.
Read MoreFor women over the age of 65 who have never had a high-risk HPV test, a “catch up” test may improve cervical cancer prevention.
Read MoreSelf-sampling with the Colli-Pee device could significantly expand access to cervical cancer screening for underserved and rural populations.
Read MoreSending HPV self-collection tests by mail and providing support to schedule in-clinic screening appointments for under-screened women increased cervical cancer screening rates by almost two times.
Read MoreRural women are six times more likely to get timely breast, cervical, and colorectal cancer screening when employing this method.
Read MoreWith the goal of improving cervical cancer care, AACC published a new guidance document with expert recommendations on detecting this cancer.
Read MoreThe triage approach offers women and labs a more efficient and effective way to diagnose and manage cervical cancer earlier.
Read MoreA new study suggests that women over the age of 65 may be undergoing unnecessary cervical cancer screenings.
Read MoreA new study found that routine screening for, and removal of, precancerous anal lesions can significantly reduce the risk of anal cancer.
Read MoreA study from the American Cancer Society evaluated the impact of the pandemic on cancer screenings nationally through population-based data.
Read MoreA new study supports the extension of cervical cancer screening intervals to five years for those with a negative screen result.
Read MoreLiquid biopsy is proving itself as both an efficacious and cost-effective way to provide a cancer diagnosis to patients.
Read MoreA recent analysis found sexual minority individuals less likely to undergo cervical cancer screening than their heterosexual counterparts.
Read MoreA new study found in a questionnaire that 51.4% of women preferred self-sampling for HPV-based cervical cancer screening.
Read MoreDeaths from cancer are expected to increase over the next decade due to screening deficits resulting from COVID-19 pandemic.
Read More